Vaxxinity, Inc. (VAXX) Reports In-Line Q4 EPS

Vaxxinity, Inc. (NASDAQ: VAXX) reported Q4 EPS of ($0.16), in-line with the analyst estimate of ($0.16).

For earnings history and earnings-related data on Vaxxinity, Inc. (VAXX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c